Search for: "GlaxoSmithKline, LLC" Results 81 - 100 of 181
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Dec 2023, 10:00 pm by Sherica Celine
Hear expert commentary from Tom Irving and Michelle O’Brien of the Marbury Law Group on the risk generic drug companies face when utilizing a skinny label in the aftermath of the Federal Circuit’s decision in Glaxosmithkline LLC v. [read post]
17 Jul 2022, 5:00 am by Dennis Crouch
GlaxoSmithKline LLC, SCT Docket No. 22-37 (2022). [read post]
3 Mar 2017, 8:32 am by Lawrence B. Ebert
GlaxoSmithKline LLC,713 F.3d 1090, 1095 (Fed. [read post]
27 Jul 2018, 10:24 am by Andrew Hamm
GlaxoSmithKline LLC v. [read post]
14 Feb 2022, 9:38 am by Dennis Crouch
by Dennis Crouch GlaxoSmithKline LLC v. [read post]
31 Jul 2011, 12:10 pm by Josh Myers
Myers is the owner and President of Myers Injury Law, LLC and a founding partner of Schultz & Myers, LLC. [read post]
6 May 2022, 8:10 am by Dennis Crouch
Cir. 2021), en banc denied at GlaxoSmithKline LLC v. [read post]
29 Mar 2024, 10:04 am by Rebecca Tushnet
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, --- F.Supp.3d ----, 2024 WL 348821, No: 4:20-cv-09077-JSW (N.D. [read post]
13 Aug 2021, 6:43 am by Rebecca Tushnet
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, No. 20-cv-09077-JSW,  2021 WL 3524047 (N.D. [read post]
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
Amgen, GlaxoSmithKline (GSK) and a group of intellectual property professors filed a trio of amicus briefs placing their support behind Idenix, warning that the future of innovation was on the line. [read post]
15 Nov 2010, 6:58 am by Mark Zamora
During the Committee's follow-uphearing on the recall of infant, children, and adult OTC products by McNeil ConsumerHealthcare, LLC (McNeil), a number of bipartisan questions were raised regarding theinvolvement of the U.S. [read post]
17 Nov 2010, 6:00 am
Recently, manufacturing problems at McNeil Consumer Healthcare, LLC's Puerto Rico facility led to an unusual "silent recall" of Motrin® (ibuprofen). [read post]
15 May 2023, 9:59 am by Jonathan H. Adler
GlaxoSmithKline LLC, which presented the question: "If a generic drug's FDA-approved label carves out all of the language that the brand manufacturer has identified as covering its patented uses, can the generic manufacturer be held liable on a theory that its label still intentionally encourages infringement of those carved-out uses? [read post]
26 Mar 2010, 7:23 am by Greenberg & Bederman
Further, the Staff Report mischaracterizes and distorts the efforts that GlaxoSmithKline LLC (“GSK”) took to continue to monitor the safety and efficacy of its diabetes medication. [read post]
28 Sep 2010, 3:14 pm by Kelly
(Patent Docs) Herceptin (Trastuzumab) – US: Patent infringement complaint: GlaxoSmithKline LLC v. [read post]